Hoth Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Hoth Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
HOTH | Hoth Therapeutics | -$0.31 | -$0.13 | — | — | $0.00 | — | — | — | 11/11/2025 | |
HOTH | Hoth Therapeutics | -$0.25 | -$0.21 | -$0.17 | 19.05% | $0.00 | — | $0.00 | — | 08/12/2025 | |
HOTH | Hoth Therapeutics | -$0.46 | -$0.27 | -$0.27 | 0.00% | $0.00 | — | $0.00 | — | 05/12/2025 | |
HOTH | Hoth Therapeutics | -$0.31 | -$0.34 | -$0.27 | 20.59% | $0.00 | — | $0.00 | — | 03/28/2025 | |
HOTH | Hoth Therapeutics | -$0.60 | -$0.32 | -$0.31 | 3.12% | $0.00 | — | $0.00 | — | 11/12/2024 | |
HOTH | Hoth Therapeutics | -$0.57 | -$0.47 | -$0.24 | 48.94% | $0.00 | — | $0.00 | — | 08/09/2024 | |
HOTH | Hoth Therapeutics | -$0.88 | -$0.43 | -$0.46 | -6.98% | $0.00 | — | $0.00 | — | 05/14/2024 | |
HOTH | Hoth Therapeutics | -$2.72 | -$0.51 | -$0.31 | 39.22% | $0.00 | — | $0.00 | — | 03/28/2024 | |
HOTH | Hoth Therapeutics | -$2.05 | -$0.72 | -$0.60 | 16.67% | $0.00 | — | $0.00 | — | 11/13/2023 | |
HOTH | Hoth Therapeutics | -$2.25 | -$1.16 | -$0.57 | 50.86% | $0.00 | — | $0.00 | — | 08/12/2023 | |
HOTH | Hoth Therapeutics | -$2.75 | -$1.16 | -$0.88 | 24.14% | $0.00 | — | $0.00 | — | 05/15/2023 | |
HOTH | Hoth Therapeutics | -$3.50 | -$2.29 | -$2.72 | -18.78% | $0.00 | — | $0.00 | — | 03/31/2023 | |
HOTH | Hoth Therapeutics | -$3.50 | — | -$2.05 | — | $0.00 | — | $0.00 | — | 11/10/2022 | |
HOTH | Hoth Therapeutics | -$3.50 | — | -$2.25 | — | $0.00 | — | $0.00 | — | 08/12/2022 | |
HOTH | Hoth Therapeutics | -$6.00 | — | -$2.75 | — | $0.00 | — | $0.00 | — | 05/12/2022 | |
HOTH | Hoth Therapeutics | -$1.00 | — | -$3.50 | — | $0.00 | — | $0.00 | — | 03/30/2022 | |
HOTH | Hoth Therapeutics | -$4.00 | — | -$3.50 | — | $0.00 | — | $0.00 | — | 11/10/2021 | |
HOTH | Hoth Therapeutics | -$5.00 | -$4.25 | -$3.50 | 17.65% | $0.00 | — | $0.00 | — | 08/11/2021 | |
HOTH | Hoth Therapeutics | -$4.50 | — | -$6.00 | — | $0.00 | — | $0.00 | — | 05/13/2021 | |
HOTH | Hoth Therapeutics | -$10.25 | — | -$1.00 | — | $0.00 | — | $0.00 | — | 03/16/2021 | |
HOTH | Hoth Therapeutics | -$4.25 | — | -$4.00 | — | $0.00 | — | $0.00 | — | 11/10/2020 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-0.17 | $-0.21 | 19.1 % |
| Q1 | 2025-05-12 | $-0.27 | $-0.27 | 0.00 % |
| Q4 | 2025-03-28 | $-0.27 | $-0.34 | 20.6 % |
| Q3 | 2024-11-12 | $-0.31 | $-0.32 | 3.12 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
Está previsto que Hoth Therapeutics (HOTH) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 12, 2025 para el Q2.
El BPA real fue de $-0.17, que superó la estimación de $-0.21.
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.